Biotechnology
/

Norda Asa
DNA BASED TECHNOLOGY FOR CANCER TESTING

Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
  • Finance
    Total revenues: 62.383
    Operating profit :27.802
    Operating profit before tax: 22.735
    Total assets: 491.397
    Total equity: 172.232
    Currency: NOK (all numbers in thousands)
  • Management
    Board Chairman:
    Christian Åbyholm

    Board Members:
    Hans Johan Hekland
    Pia E Hverven Axell

    General Manager:
    Frode Westvold

    Subsidiary companies:
    Largest shareholders:
    N/A
    Biotechnology,